← Evidence map

ArticleFrontiers in pharmacology2026

Correction: Xinnaoxin tablets ameliorate high-altitude polycythemia-associated cardiac injury by regulating the NF-κB, MAPK, and PI3K/AKT signaling pathways.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Correction: Xinnaoxin tablets ameliorate high-altitude polycythemia-associated cardiac injury by regulating the NF-κB, MAPK, and PI3K/AKT signaling pathways. | Socratic